Regulation of chromatin by histone modifications

Allfrey VG, Faulkner R, Mirsky AE . Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964; 51:786–794.

Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ . Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389:251–260.

Xhemalce B, Dawson MA, Bannister AJ . Histone modifications. In: Meyers R, ed. Encyclopedia of Molecular Cell Biology and Molecular Medicine. John Wiley and Sons, 2011: In Press.

Parthun MR . Hat1: the emerging cellular roles of a type B histone acetyltransferase. Oncogene 2007; 26:5319–5328.

Hodawadekar SC, Marmorstein R . Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene 2007; 26:5528–5540.

Yang XJ, Seto E . HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007; 26:5310–5318.

Tjeertes JV, Miller KM, Jackson SP . Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J 2009; 28:1878–1889.

Das C, Lucia MS, Hansen KC, Tyler JK . CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009; 459:113–117.

Grant PA, Duggan L, Cote J, et al. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev 1997; 11:1640–1650.

Yang XJ, Seto E . The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 2008; 9:206–218.

Dovey OM, Foster CT, Cowley SM . Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci USA 2010; 107:8242–8247.

Oki M, Aihara H, Ito T . Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell Biochem 2007; 41:319–336.

Hu S, Xie Z, Onishi A, et al. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 2009; 139:610–622.

Dawson MA, Bannister AJ, Gottgens B, et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009; 461:819–822.

Sugiyama K, Sugiura K, Hara T, et al. Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 2002; 21:3103–3111.

Goto H, Yasui Y, Nigg EA, Inagaki M . Aurora-B phosphorylates histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 2002; 7:11–17.

Ng SS, Yue WW, Oppermann U, Klose RJ . Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 2009; 66:407–422.

Bedford MT, Clarke SG . Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009; 33:1–13.

Lan F, Shi Y . Epigenetic regulation: methylation of histone and non-histone proteins. Sci China C Life Sci 2009; 52:311–322.

Rea S, Eisenhaber F, O'Carroll D, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406:593–599.

Tamaru H, Zhang X, McMillen D, et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet 2003; 34:75–79.

Xiao B, Jing C, Wilson JR, et al. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 2003; 421:652–656.

Zhang X, Yang Z, Khan SI, et al. Structural basis for the product specificity of histone lysine methyltransferases. Mol Cell 2003; 12:177–185.

Cheng X, Collins RE, Zhang X . Structural and sequence motifs of protein (histone) methylation enzymes. Annu Rev Biophys Biomol Struct 2005; 34:267–294.

Collins RE, Tachibana M, Tamaru H, et al. In vitro and in vivo analyses of a Phe/Tyr switch controlling product specificity of histone lysine methyltransferases. J Biol Chem 2005; 280:5563–5570.

Wolf SS . The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci 2009; 66:2109–2121.

Copeland RA, Solomon ME, Richon VM . Protein methyltransferases as a target class for drug discovery. Nat Rev Drug Discov 2009; 8:724–732.

Bannister AJ, Schneider R, Kouzarides T . Histone methylation: dynamic or static? Cell 2002; 109:801–806.

Cuthbert GL, Daujat S, Snowden AW, et al. Histone deimination antagonizes arginine methylation. Cell 2004; 118:545–553.

Wang Y, Wysocka J, Sayegh J, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004; 306:279–283.

Chang B, Chen Y, Zhao Y, Bruick RK . JMJD6 is a histone arginine demethylase. Science 2007; 318:444–447.

Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941–953.

Klose RJ, Zhang Y . Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8:307–318.

Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439:811–816.

Whetstine JR, Nottke A, Lan F, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125:467–481.

Mosammaparast N, Shi Y . Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010; 79:155–179.

Sakabe K, Wang Z, Hart GW . {beta}-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA 2010; 107:19915–19920.

Hassa PO, Haenni SS, Elser M, Hottiger MO . Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 2006; 70:789–829.

Cohen-Armon M, Visochek L, Rozensal D, et al. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell 2007; 25:297–308.

Krishnakumar R, Kraus WL . PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39:736–749.

Hershko A, Ciechanover A . The ubiquitin system. Annu Rev Biochem 1998; 67:425–479.

Wang H, Wang L, Erdjument-Bromage H, et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004; 431:873–878.

Lee JS, Shukla A, Schneider J, et al. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 2007; 131:1084–1096.

Kim J, Guermah M, McGinty RK, et al. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009; 137:459–471.

Seeler JS, Dejean A . Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003; 4:690–699.

Shiio Y, Eisenman RN . Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 2003; 100:13225–13230.

Nathan D, Ingvarsdottir K, Sterner DE, et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 2006; 20:966–976.

Allis CD, Bowen JK, Abraham GN, Glover CV, Gorovsky MA . Proteolytic processing of histone H3 in chromatin: a physiologically regulated event in Tetrahymena micronuclei. Cell 1980; 20:55–64.

Santos-Rosa H, Kirmizis A, Nelson C, et al. Histone H3 tail clipping regulates gene expression. Nat Struct Mol Biol 2009; 16:17–22.

Duncan EM, Muratore-Schroeder TL, Cook RG, et al. Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 2008; 135:284–294.

Nelson CJ, Santos-Rosa H, Kouzarides T . Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 2006; 126:905–916.

Chen Z, Zang J, Whetstine J, et al. Structural insights into histone demethylation by JMJD2 family members. Cell 2006; 125:691–702.

Kouzarides T . Chromatin modifications and their function. Cell 2007; 128:693–705.

Kiefer CM, Hou C, Little JA, Dean A . Epigenetics of beta-globin gene regulation. Mutat Res 2008; 647:68–76.

Wang Z, Zang C, Rosenfeld JA, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40:897–903.

Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL . Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311:844–847.

Wei Y, Mizzen CA, Cook RG, Gorovsky MA, Allis CD . Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc Natl Acad Sci USA 1998; 95:7480–7484.

Hirota T, Lipp JJ, Toh BH, Peters JM . Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 2005; 438:1176–1180.

Fischle W, Tseng BS, Dormann HL, et al. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 2005; 438:1116–1122.

Vermeulen M, Eberl HC, Matarese F, et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010; 142:967–980.

Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T . Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010; 143:470–484.

Champagne KS, Kutateladze TG . Structural insight into histone recognition by the ING PHD fingers. Curr Drug Targets 2009; 10:432–441.

Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP . The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 2003; 28:69–74.

Kim J, Daniel J, Espejo A, et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep 2006; 7:397–403.

Shi X, Hong T, Walter KL, et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006; 442:96–99.

Sims RJ, III, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg D . Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 2005; 280:41789–41792.

Huang Y, Fang J, Bedford MT, Zhang Y, Xu RM . Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 2006; 312:748–751.

Bannister AJ, Zegerman P, Partridge JF, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410:120–124.

Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T . Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410:116–120.

Daujat S, Zeissler U, Waldmann T, Happel N, Schneider R . HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding. J Biol Chem 2005; 280:38090–38095.

Trojer P, Li G, Sims RJ, III, et al. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 2007; 129:915–928.

Mujtaba S, Zeng L, Zhou MM . Structure and acetyl-lysine recognition of the bromodomain. Oncogene 2007; 26:5521–5527.

Hassan AH, Prochasson P, Neely KE, et al. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 2002; 111:369–379.

Zeng L, Zhang Q, Li S, Plotnikov AN, Walsh MJ, Zhou MM . Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 2010; 466:258–262.

Clayton AL, Rose S, Barratt MJ, Mahadevan LC . Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J 2000; 19:3714–3726.

Macdonald N, Welburn JP, Noble ME, et al. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell 2005; 20:199–211.

Karam CS, Kellner WA, Takenaka N, Clemmons AW, Corces VG . 14-3-3 mediates histone cross-talk during transcription elongation in Drosophila. PLoS Genet 2010; 6:e1000975.

Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP . MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005; 123:1213–1226.

Nishioka K, Chuikov S, Sarma K, et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 2002; 16:479–489.

Zegerman P, Canas B, Pappin D, Kouzarides T . Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem 2002; 277:11621–11624.

Adams-Cioaba MA, Min J . Structure and function of histone methylation binding proteins. Biochem Cell Biol 2009; 87:93–105.

Schneider R, Bannister AJ, Weise C, Kouzarides T . Direct binding of INHAT to H3 tails disrupted by modifications. J Biol Chem 2004; 279:23859–23862.

Xhemalce B, Kouzarides T . A chromodomain switch mediated by histone H3 Lys 4 acetylation regulates heterochromatin assembly. Genes Dev 2010; 24:647–652.

Filion GJ, van Bemmel JG, Braunschweig U, et al. Systematic protein location mapping reveals five principal chromatin types in Drosophila cells. Cell 2010; 143:212–224.

Ong CT, Corces VG . Insulators as mediators of intra- and inter-chromosomal interactions: a common evolutionary theme. J Biol 2009; 8:73.

Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823–837.

Trojer P, Reinberg D . Facultative heterochromatin: is there a distinctive molecular signature? Mol Cell 2007; 28:1–13.

Hansen KH, Bracken AP, Pasini D, et al. A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol 2008; 10:1291–1300.

Hon GC, Hawkins RD, Ren B . Predictive chromatin signatures in the mammalian genome. Hum Mol Genet 2009; 18:R195–201.

Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T . Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 2004; 6:73–77.

Bannister AJ, Schneider R, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T . Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. J Biol Chem 2005; 280:17732–17736.

Ng HH, Robert F, Young RA, Struhl K . Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell 2003; 11:709–719.

Xiao T, Hall H, Kizer KO, et al. Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev 2003; 17:654–663.

Taverna SD, Ilin S, Rogers RS, et al. Yng1 PHD finger binding to H3 trimethylated at K4 promotes NuA3 HAT activity at K14 of H3 and transcription at a subset of targeted ORFs. Mol Cell 2006; 24:785–796.

Carrozza MJ, Li B, Florens L, et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005; 123:581–592.

Li B, Gogol M, Carey M, Lee D, Seidel C, Workman JL . Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science 2007; 316:1050–1054.

Zhang HS, Gavin M, Dahiya A, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101:79–89.

Nielsen SJ, Schneider R, Bauer UM, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001; 412:561–565.

Liang J, Prouty L, Williams BJ, Dayton MA, Blanchard KL . Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 1998; 92:2118–2122.

Carapeti M, Aguiar RC, Goldman JM, Cross NC . A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 1998; 91:3127–3133.

Champagne N, Pelletier N, Yang XJ . The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 2001; 20:404–409.

Torchia J, Rose DW, Inostroza J, et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997; 387:677–684.

Huntly BJ, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6:587–596.

Deguchi K, Ayton PM, Carapeti M, et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 2003; 3:259–271.

Campbell PJ, Green AR . The myeloproliferative disorders. N Engl J Med 2006; 355:2452–2466.

Levine RL, Pardanani A, Tefferi A, Gilliland DG . Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7:673–683.

Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH . The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 1998; 95:3890–3895.

McCormack MP, Rabbitts TH . Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2004; 350:913–922.

Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 2003; 100:11606–11611.

Weikert S, Christoph F, Kollermann J, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med 2005; 16:349–353.

Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419:624–629.

Ernst T, Chase AJ, Score J, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42:722–726.

Nikoloski G, Langemeijer SM, Kuiper RP, et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 2010; 42:665–667.

van Haaften G, Dalgliesh GL, Davies H, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009; 41:521–523.

Oda H, Okamoto I, Murphy N, et al. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol Cell Biol 2009; 29:2278–2295.

Peters AH, O'Carroll D, Scherthan H, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001; 107:323–337.

Sharma S, Kelly TK, Jones PA . Epigenetics in cancer. Carcinogenesis 2010; 31:27–36.

Best JD, Carey N . Epigenetic opportunities and challenges in cancer. Drug Discov Today 2010; 15:65–70.

Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311–1323.

Kanhere A, Viiri K, Araujo CC, et al. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell 2010; 38:675–688.

Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329:689–693.

Moazed D . Small RNAs in transcriptional gene silencing and genome defence. Nature 2009; 457:413–420.

Koziol MJ, Rinn JL . RNA traffic control of chromatin complexes. Curr Opin Genet Dev 2010; 20:142–148.

Mattick JS . The genetic signatures of noncoding RNAs. PLoS Genet 2009; 5:e1000459.

Bungard D, Fuerth BJ, Zeng PY, et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 2010; 329:1201–1205.

Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A . An operational definition of epigenetics. Genes Dev 2009; 23:781–783.

Rassoulzadegan M, Grandjean V, Gounon P, Vincent S, Gillot I, Cuzin F . RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 2006; 441:469–474.

Kouzarides T, Berger SL . Chromatin modifications and their mechanism of action. In: Allis CD, Jenuwein T, Reinberg D, eds. Epigenetics, New York: Cold Spring Harbor Laboratory Press, 2007:191–210.